Polycystic ovary syndrome (PCOS) is one of the most common endocrine conditions affecting women, yet it continues to be underdiagnosed, inconsistently managed, and frequently misunderstood across health services. For many patients, the journey to diagnosis is long and fragmented, often involving repeated consultations, delayed recognition, and limited continuity of care.

For the nursing workforce, this is not an abstract clinical issue, it is a daily reality. Nurses are often the first point of contact for people presenting with symptoms such as irregular periods, weight changes, infertility concerns, acne, or fatigue. In general practice, urgent care, and women’s health services, nurses are uniquely placed to recognise early signs, initiate investigations, and provide ongoing support. Yet the ability to do this consistently is increasingly constrained by workforce pressures and rising demand.

The All-Party Parliamentary Group (APPG) on the Nursing Workforce (All-Party Parliamentary Group on the Nursing Workforce) has repeatedly highlighted a system under strain: persistent shortages, high levels of burnout, and growing complexity of patient need. These pressures directly affect the quality and continuity of care delivered, particularly in long-term conditions like PCOS, where time for education, follow-up, and relational care is essential.

When capacity is limited, PCOS care becomes reactive rather than proactive. Consultations are often focused on symptom management rather than broader metabolic risk, cardiovascular prevention, or psychological wellbeing. Opportunities for early intervention are missed, and patients are frequently left to navigate a complex condition with limited structured support.

This is where the role of nursing within women’s health becomes critical. With adequate staffing and investment, nurses can deliver continuity, education, and preventative care that significantly improves long-term outcomes for people with PCOS. Without it, even the best clinical guidance struggles to translate into consistent practice.

Patient-led organisations also continue to play a vital role in bridging gaps in care. Verity PCOS UK based charity, remains a key source of support, information, and advocacy for those living with PCOS. Its work highlights both the strength of patient communities and the ongoing variability in clinical experience. For many, Verity provides the continuity, reassurance, and education that health systems are not always able to deliver.

At policy level, the APPG for PCOS (All-Party Parliamentary Group on PCOS) has helped elevate PCOS as a priority within women’s health. One of the most significant areas of discussion it has supported is whether the term “polycystic ovary syndrome” remains fit for purpose.

Many clinicians and patient advocates argue that the name is misleading. It places emphasis on ovarian appearance rather than the broader endocrine and metabolic nature of the condition. This can contribute to misunderstanding among both patients and healthcare professionals, potentially delaying diagnosis and reinforcing stigma. The ongoing discussion around renaming PCOS reflects a wider shift towards language that better communicates complexity and supports earlier recognition.

Within the National Health Service, these issues sit alongside wider system challenges. Nurses are being asked to deliver increasingly complex care within constrained time and staffing models, limiting opportunities for prevention, health promotion, and continuity, core components of effective PCOS management.

For the Royal College of Nursing (RCN), this intersection between workforce sustainability and women’s health outcomes is central. PCOS is a clear example of how workforce capacity directly influences equity of access, diagnostic timeliness, and quality of long-term care. Strengthening women’s health services therefore requires not only clinical innovation, but sustained investment in the nursing workforce that underpins it.

What PCOS highlights is a wider truth in women’s health: outcomes are shaped as much by system capacity as by clinical knowledge. Without adequate nursing numbers, protected time, and recognition of advanced practice roles in women’s health, patients will continue to experience variation in care that is both avoidable and inequitable.

If we are serious about improving women’s health outcomes, PCOS must be seen not as a niche endocrine condition, but as a marker of how well services are functioning. And at the heart of that response is nursing, leading, coordinating, and delivering the continuity of care that women’s health demands.